Form 4 for ADPT Adaptive Biotechnologies Corp
Accepted 2026-02-06 00:00:00 ET · period of report 2026-02-04 · accession 0001780662-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-06 | 2026-02-04 | ADPT | PISKEL KYLE | CFO | S - Sale+OE | $18.46 | -2,145 | 216.6K | -1.0% | -$39.6K |
| D | 2026-02-06 | 2026-02-04 | ADPT | PISKEL KYLE | CFO | M - OptEx | $12.14 | +2,145 | 218.8K | +1.0% | +$26.0K |
| D | 2026-02-06 | 2026-02-04 | ADPT | PISKEL KYLE | CFO | M - OptEx | $0.00 | -2,145 | 2,146 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-04 | S | D | 2,145 | $18.46 | 216,637 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-04 | M | A | 2,145 | $12.14 | 218,782 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2026-02-04 | M | D | 2,145 | $0.00 | 2,146 | D | $12.14 · — to 2032-03-04 | 2,145 Common Stock | (F2) The options vested with respect to 1/4 of such shares on March 4, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. |